Stage IV
Oncology
49 drugs in development·11 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| opdivo qvantig | BRISTOL MYERS SQUIBB CO (BMY) |
Phase 3(14)
Phase 2(21)
Phase 1(6)
Preclinical(1)
Early Phase 1(1)
| Drug | Company |
|---|---|
| C-peptide | ENANTA PHARMACEUTICALS INC (ENTA) |
N/A(1)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| leucovorin | GH Research PLC (GHRS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Stage IV?
BioSniper tracks 49 drugs in development for Stage IV across 11 companies.
How many clinical trials target Stage IV?
There are 1 clinical trial targeting Stage IV tracked by BioSniper.
Deep-dive into Stage IV
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis